 |
|
One Thousand Fifty-Six Hepatectomies Without Mortality in 8 Years
Hiroshi Imamura, MD, PhD;
Yasuji Seyama, MD;
Norihiro Kokudo, MD, PhD;
Atsushi Maema, MD, PhD;
Yasuhiko Sugawara, MD, PhD;
Keiji Sano, MD, PhD;
Tadatoshi Takayama, MD, PhD;
Masatoshi Makuuchi, MD, PhD
Arch Surg. 2003;138:1198-1206.
Background Despite improvements in diagnostic and surgical techniques, operative mortality associated with liver resection is still greater than 2% in most of the recent studies.
Hypothesis By refining preoperative and postoperative care and surgical skills, liver resection mortality can be decreased to zero.
Design Retrospective cohort study to analyze postoperative morbidity and mortality in 1056 consecutive hepatectomies performed at a single medical center during 8 years.
Setting Tertiary referral center.
Patients A total of 915 patients who underwent 1056 consecutive hepatic resections: 532 for hepatocellular carcinoma, 262 for other primary and secondary liver malignancies, 57 for biliary tract malignancy, 174 for living donor liver transplantation, and 31 for other benign diseases.
Main Outcome Measures Operative mortality and morbidity rates.
Results No operative mortality occurred. Major complications, as defined by postoperative radiologic or surgical intervention, occurred in 3% of patients with hepatocellular carcinoma, 8% with other liver malignancy, 28% with biliary malignancy, and 5% of living donor liver transplantation donors. Using multiple logistic regression, independent risk factors associated with major complications were operative blood loss of 1000 mL or greater for hepatocellular carcinoma and total bilirubin level of 1.0 mg/dL or greater ( 17 µmol/L) and operative time greater than 6 hours for other liver malignancy. No independent factors associated with major complications were identified for biliary malignancy or for living donor liver transplantation donors among the variables investigated in this study.
Conclusions Liver resection can be performed without mortality provided that it is carried out in a high-volume medical center by well-trained hepatobiliary surgeons paying meticulous attention to the balance between the liver functional reserve and the volume of liver to be removed.
From the Division of Hepato-Biliary-Pancreatic Surgery and Artificial Organ and Transplantation, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
RELATED ARTICLES
This Month in Archives of Surgery
Arch Surg. 2003;138(11):1172.
FULL TEXT
One Thousand Fifty-Six Hepatectomies Without Mortality in 8 Years—Invited Critique
Stephen E. Ettinghausen
Arch Surg. 2003;138(11):1206.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Short- and Long-Term Outcomes after Hepatic Resection for Hepatocellular Carcinoma with Concomitant Esophageal Varices in Patients with Cirrhosis
Kawano et al.
Ann. Surg. Oncol. 2008;15:1670-1676.
ABSTRACT
| FULL TEXT
Selection for Resection of Hepatocellular Carcinoma and Surgical Strategy: Indications for Resection, Evaluation of Liver Function, Portal Vein Embolization, and Resection
Ribero et al.
Ann. Surg. Oncol. 2008;15:986-992.
FULL TEXT
Perihepatic Lymph Node Micrometastases Impact Outcome after Partial Hepatectomy for Colorectal Metastases
Bennett et al.
Ann. Surg. Oncol. 2008;15:1130-1136.
ABSTRACT
| FULL TEXT
Use of Vascular Clamping in Hepatic Surgery: Lessons Learned From 1260 Liver Resections
Ercolani et al.
Arch Surg 2008;143:380-387.
ABSTRACT
| FULL TEXT
Liver Resection With a New Multiprobe Bipolar Radiofrequency Device
Ayav et al.
Arch Surg 2008;143:396-401.
ABSTRACT
| FULL TEXT
Simultaneous Resections of Colorectal Cancer and Synchronous Liver Metastases: A Multi-institutional Analysis
Reddy et al.
Ann. Surg. Oncol. 2007;14:3481-3491.
ABSTRACT
| FULL TEXT
A Critical Appraisal of the Role of Neoadjuvant Chemotherapy for Colorectal Liver Metastases: A Case-Controlled Study
Malik et al.
Ann. Surg. Oncol. 2007;14:3519-3526.
ABSTRACT
| FULL TEXT
Intra-operative Blood Loss Predicts Complications After a Second Hepatectomy for Malignant Neoplasms
Tanaka et al.
Ann. Surg. Oncol. 2007;14:2668-2677.
ABSTRACT
| FULL TEXT
Analysis of Prognostic Factors Affecting Survival After Initial Recurrence and Treatment Efficacy for Recurrence in Patients Undergoing Potentially Curative Hepatectomy for Hepatocellular Carcinoma
Shimada et al.
Ann. Surg. Oncol. 2007;14:2337-2347.
ABSTRACT
| FULL TEXT
Tumor Size and Operative Risks of Extended Right-Sided Hepatic Resection for Hepatocellular Carcinoma: Implication for Preoperative Portal Vein Embolization
Chik et al.
Arch Surg 2007;142:63-69.
ABSTRACT
| FULL TEXT
A Gene Expression Profile for Vascular Invasion can Predict the Recurrence After Resection of Hepatocellular Carcinoma: a Microarray Approach
Ho et al.
Ann. Surg. Oncol. 2006;13:1474-1484.
ABSTRACT
| FULL TEXT
Bile Leakage and Liver Resection: Where Is the Risk?
Capussotti et al.
Arch Surg 2006;141:690-694.
ABSTRACT
| FULL TEXT
Solitary Colorectal Liver Metastasis: Resection Determines Outcome
Aloia et al.
Arch Surg 2006;141:460-467.
ABSTRACT
| FULL TEXT
Incidence of Unsuspected and Treatable Metastatic Disease Associated With Operable Colorectal Liver Metastases Discovered Only at Laparotomy (and Not Treated When Performing Percutaneous Radiofrequency Ablation)
Elias et al.
Ann. Surg. Oncol. 2005;12:298-302.
ABSTRACT
| FULL TEXT
Giant Cavernous Liver Hemangiomas: Effect of Operative Approach on Outcome
Lerner et al.
Arch Surg 2004;139:818-823.
ABSTRACT
| FULL TEXT
|
